Rivastigmine - RIVASTIGMINE ZENTIVA 4,6 mg/24 heures, dispositif transdermique

Business Listing - December 25, 2019

Rivastigmine RIVASTIGMINE ZENTIVA 4,6 mg/24 heures, dispositif transdermique - N06DA03 SANOFI AVENTIS FRANCE - 63290816

This is a premium business listing. Stand out from the competition!

List your company and reach more customers today.